Skip to main content
. 2021 May 24;8:652311. doi: 10.3389/fnut.2021.652311

Table 1.

The baseline characteristics of the participants classified by liver function.

Non-liver-injury groupa Liver injury group Normal liver function group Liver dysfunction group
n Valueb n Value Pc n Value n Value P
Age 556 50.0 (35.8) 49 43.0 (30.0) 0.153 464 50.5 (37.0) 141 46.0 (28.5) 0.054
Gender 556 49 0.429 464 141 0.107
   Male 402 (72.3%) 38 (77.6%) 330 (71.1%) 110 (78.0%)
   Female 154 (27.7%) 11 (22.4%) 134 (28.9%) 31 (22.0%)
Area 0.000 464 141 0.000
   Qingdao 179 (32.2%) 31 (63.3%) 129 (27.8%) 81 (57.4%)
   Linyi 377 (67.8%) 18 (36.7%) 335 (72.2%) 60 (42.6%)
BMI, kg/m2 551 20.8 ± 2.9 49 21.4 ± 3.0 0.133 459 20.7 ± 2.8 141 21.1 ± 3.3 0.154
Smoking 556 119 (21.4%) 49 10 (20.4%) 1.000 464 104 (22.4%) 141 25 (17.7%) 0.290
Alcohol consumption 556 88 (15.8%) 49 8 (16.3%) 0.841 464 69 (14.9%) 141 27 (19.1%) 0.237
Marital status 549 49 0.592 457 141 0.424
   Single 127 (23.1%) 11 (22.4%) 110 (24.1%) 28 (19.9%)
   Married 402 (73.2%) 38 (77.6%) 330 (72.2%) 110 (78.0%)
   Widowed 17 (3.1%) 0 (0.0%) 15 (3.3%) 2 (1.4%)
   Divorced 3 (0.5%) 0 (0.0%) 2 (0.4%) 1 (0.7%)
Education completed 550 48 0.001 458 140 0.000
   None 78 (14.2%) 2 (4.2%) 76 (16.6%) 4 (2.9%)
   Primary school 134 (24.4%) 4 (8.3%) 112 (24.5%) 26 (18.6%)
   Class VII-IX 203 (36.9%) 20 (41.7%) 164 (35.8%) 59 (42.1%)
   Class X-XII 92 (16.7%) 12 (25.0%) 73 (15.9%) 31 (22.1%)
   Diploma or higher 43 (7.8%) 10 (20.8%) 33 (7.2%) 20 (14.3%)
History of liver diseasesd 550 6 (1.1%) 49 2 (4.1%) 0.134 458 5 (1.1%) 141 3 (2.1%) 0.400
Diabetes 554 87 (15.7%) 49 13 (26.5%) 0.051 462 70 (15.2%) 141 30 (21.3%) 0.087
Outdoor exercise 553 49 0.386 461 141 0.004
   Almost none 24 (4.3%) 3 (6.1%) 19 (4.1%) 8 (5.7%)
   <2 h per day 181 (32.7%) 20 (40.8%) 139 (30.2%) 62 (44.0%)
   >2 h per day 348 (62.9%) 26 (53.1%) 303 (65.7%) 71 (50.4%)
a

Liver injury group had an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level of higher than two times of the upper limit of normal (ULN); Non-liver-injury group had an ALT and AST level of equal or lower than two times of the ULN. Liver dysfunction had an ALT or AST level of higher than the ULN; Normal liver function group had an ALT and AST level of equal or lower than the ULN. The ULN for ALT and AST is 40 U/L.

b

Non-normal variables were presented as median (IQR); normal variables were presented as mean ± SD; categorical variables were presented as number of patients in a specific category (percentage).

c

P was calculated between the non-liver-injury group and liver injury group, and between the normal liver function group and liver dysfunction group. The statistical difference for the non-normal data was tested by a Mann-Whitney U-test; the difference for the normal data was tested by a t-test; the difference for the categorical data was tested by a χ2-test.

d

The intergroup difference for the history of liver diseases was tested by a Fisher's exact-test. P values were labeled in bold if they were less than 0.05.